Skip to main content
. Author manuscript; available in PMC: 2021 Aug 6.
Published in final edited form as: Mol Psychiatry. 2020 Feb 6;26(8):4288–4299. doi: 10.1038/s41380-020-0666-z

Table 1.

Demographic and Clinical Information

Responders Nonresponders Controls
Sample Size n = 18 n = 26 n = 36
Age, mean (SD) 43.53 (13.17) 39.50 (13.97) 39.06 (12.29)
Sex, females/males 7/10 16/10 19/17
Clinical Information
 Diagnosis, unipolar/bipolar 13/4 21/5
 Age at 1st diagnosed depressive episode, mean (SD) 27.24 (12.31) 23.12 (12.14)
 ECT electrode placement, only-RUL/other 15/2 11/15a
 Number of ECT Index Treatments 10.35 (2.62) 12.62 (3.57)a
Baseline Study Visit
 HAM-17, mean (SD) 27.06 (5.60) 22.27 (4.98)a
 MADRS, mean (SD) 43.71 (7.40) 33.69 (5.73)a
 QIDS-SR, mean (SD) 21.71 (3.51) 18.73 (3.99)a
 Corrected Sample Size, ASL/Other 18/18 26/26 32/32
Post-2tx Study Visit
 HAM-17, mean (SD) 19.88 (6.20)b,c 16.5 (7.55)a,b,c
 MADRS, mean (SD) 32.76 (7.78)b,c 25.20 (11.83)b,c
 QIDS-SR, mean (SD) 16.35 (4.65)b,c 14.60 (6.67)b,c
 Corrected Sample Size, ASL/Other 17/18 26/26 n/a
Post-Index (4wk) Study Visit
 HAM-17, mean (SD) 7.12 (3.53)b,c 17.50 (6.23)a,b,c
 MADRS, mean (SD) 8.59 (5.30)b,c 26.35 (8.04)a,b
 QIDS-SR, mean (SD) 6.76 (4.02)b,c 14.23 (4.81)a,b,c
 Corrected Sample Size, ASL/Other 17/18 26/26 33/33
Post-6mo Study Visit
 HAM-17, mean (SD) 12.80 (8.23)b,c 10.71 (6.91)b,c
 MADRS, mean (SD) 18.20 (13.41)b,c 16.00 (11.70)b,c
 QIDS-SR, mean (SD) 11.13 (5.57)b,c 9.65 (6.11)b,c
 Corrected Sample Size, ASL/Other 14/15 18/18 n/a

Results of chi-squared and t-tests are indicated as follows:

a

Significant difference between Responders and Nonresponders, p < 0.05,

b

significant difference between baseline and follow-up (within group), p < 0.005,

c

Significant difference from previous visit (within group), p < 0.02. All other comparisons were not significant.